
Tishman Speyer signs global pharma firm for Paddington scheme
Published on 6 February 2024
The investor and developer has signed pharmaceutical firm Ipsen Biopharm for 18,000 sq ft.

The investor and developer has signed pharmaceutical firm Ipsen Biopharm for 18,000 sq ft.